Autobio Diagnostics Co. Ltd Financials

Market Capitalization CN¥23.32 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	18.24
Forward PE	14.44
Price to Sales TTM	CN¥5.09
Price to Book MRQ	CN¥2.73
Enterprise to Revenue	4.94
Enterprise to EBITDA	13.18

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	27.78%
Operating Margin	31.99%
Return on Assets TTM	7.05%
Return on Equity TTM	15.18%

Income Statement

Revenue TTM	CN¥4,581,193,216
Revenue per Share TTM	CN¥7.92
Quarterly Revenue Growth	3.40%
Gross Profit TTM	CN¥2,963,659,264
EBITDA	CN¥1,477,370,292
Net Income to Common TTM	CN¥1,272,692,992
Diluted EPS TTM	CN¥2.20
Quarterly Earnings Growth YoY	-5.20%

Balance Sheet

Total Cash MRQ	CN¥832,151,488
Total Cash per Share MRQ	CN¥1.46
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	6.83
Current Ratio MRQ	2.57
Book Value per Share MRQ	CN¥14.69

Cash Flow

Operating Cash Flow TTM	CN¥1,467,708,288
Levered Free Cash Flow TTM	CN¥1,303,074,560

603658 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	581,011,008
Float Shares	166,978,901
Avg 10 Volume	1,759,077
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	70.17%
% Held by Institutions	9.26%

Stock Price Summary

Beta	-0.01
Fifty Two Week Low	CN¥37.56
Fifty Two Week High	CN¥66.36
Fifty Two Week Change	-14.95%
Day 50 MA	CN¥43.86
Day 200 MA	CN¥45.74

Dividends and Splits

Forward Annual Dividend Rate	CN¥4.21
Forward Annual Dividend Yield	10.49%
Trailing Annual Dividend Rate	CN¥1.05
Trailing Annual Dividend Yield	2.62%
Payout Ratio	47.82%
Dividend Date
Ex Dividend Date	2024-06-05
Last Split Factor
Last Split Date	2021-05-27